The move
As of Sep 16, DataMeds AI (MEDS) last traded around $5.95, up 87.2% on the session and up 267.3% after hours, on $105.4M of dollar volume.
Why it is on our radar
Our radar flagged MEDS for up 87%, heavy scanner alerts. It fired 55 of our alerts.
What the numbers show
Market cap is about $5.0M; the tradeable float is roughly 3.0M shares (ultra-low float); short interest sits near 6% of float, about 1.0 days to cover; institutions hold around 2.15%.
The dilution picture
SEC filings flag a dilution risk here: Active shelf on file, the company can issue new shares on demand (valid ~3 years). It is worth knowing before chasing a move, because new shares can cap a run.
The latest SEC filing
The most recent SEC filing on record is Preliminary information statement (Aug 31, 2026).
How we built this
MEDS was surfaced by our trending engine, which ranks stocks by real-time move, dollar volume, alert activity, and community chatter. The fundamentals, float, short interest, and filings come straight from our due-diligence data, sourced from SEC EDGAR. Nothing here is a fabricated stat, and nothing here is a recommendation.
Why is MEDS moving?
DataMeds AI is up on $105.4M of volume and ranks near the top of our trending board for up 87% and heavy scanner alerts. This reflects what our data shows as of Sep 16, not a forecast.
Is MEDS heavily shorted?
Short interest in MEDS is around 6% of its float, roughly 1.0 days to cover, as of the most recent data we have.
Is this investment advice?
No. This is information and education built from public data, not investment advice, and we are not licensed financial advisors.